What is the current share price of Stevanato Group SpA?
Stevanato Group S.p.A. trades on the New York Stock Exchange under the ticker symbol STVN at a market price of approximately $19.85 per share. The global provider of containment and delivery solutions for the biopharmaceutical industry experiences continuous valuation shifts during trading sessions based on healthcare sector demand, quarterly financial reports, and institutional investor sentiment.
Related FAQs
The GEO Group, Inc.
Stevanato Group S.p.A.
Tod's S.p.A.
As of July 26, 2026, the estimated net worth of Steven Roth is at least $422 million, primarily based on his substantial insider holdings in Vornado Realty Trust and other real estate entities.
Stevanato Group SpA, trading under the ticker symbol STVN, is frequently viewed by equity analysts as a compelling purchase, supported by strong global demand for specialized containment and delivery systems for the biopharmaceutical industry.
Tod's S.p.A.
CIR S.p.A. (Compagnie Industriali Riunite) shares trade on Euronext Milan under ticker CIRI at approximately €0.719 per share.
Stevanato Group S.p.A.
Beam Therapeutics officially completed its initial public offering and began trading its shares on the Nasdaq Global Select Market under the ticker symbol BEAM on February 6, 2020.
STVN represents the stock ticker symbol or corporate shorthand for various emerging biotechnology or pharmaceutical entities—most notably specialized clinical-stage therapeutic firms focusing on novel treatments for genetic, metabolic, or oncological...